Professor Philip Hogg
Chair in Translational Cancer Research for Sydney Catalyst
NH&MRC Clinical Trials Centre.
Member of the Charles Perkins Centre
|
Current research students
Project title | Research student |
---|---|
Redox regulation of platelet integrin function | Aster PIJNING |
Characterisation and targeting of glucose metabolism in brain tumours. | Reichelle YEO |
Selected grants
2018
- Essential role of ERp5 in thrombosis; Hogg P, Passam F, Zhu C; National Health and Medical Research Council (NHMRC)/Project Grants.
- Redefining the pro-thrombotic mechanism of von Willebrand factor; Hogg P, Flaumenhaft R; National Health and Medical Research Council (NHMRC)/Project Grants.
2017
- 2016 Australia-Harvard Fellowships- Bruce Furie; Furie B, Furie B, Hogg P; Harvard Club of Australia Foundation/Research Support.
- ACRF Equipment (DVCR-583); Hogg P; DVC Research/Co-Fund ACRF.
2016
- Sydney Catalyst - the Translational Cancer Research Centre of central Sydney and regional NSW; Boyer M, Simes R, Hogg P, Butow P, Thomas D, Young J, Vadas M; Cancer Institute NSW/Translational Cancer Research Centre.
- Regulation of the haemostatic activity of plasma von Willebrand factor; Hogg P; National Health and Medical Research Council (NHMRC)/Career Awards: Research Fellowships.
- Wyatt DynaPro NanoStar dynamic light scattering instrument; Mackay J, Matthews J, Sunde M, Ryan R, Hogg P; National Health and Medical Research Council (NHMRC)/Equipment Grants.
2015
- The Ghost in the Machine: Understanding how blood coagulation is controlled by protein disulphide bonds; Hogg P; National Health and Medical Research Council (NHMRC)/Career Awards: Research Fellowships.
2011
- Metabolism inhibitors for the treatment of brain and pancreatic cancer; Hogg P; Cancer Council New South Wales/Program Grant.
Selected publications
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|